Trulicity® (Dulaglutide)

Name: Trulicity (dulaglutide) 0.75mg & 1.5mg pens
Brand: Trulicity
SKU: TRULICITY
Price: 229.79 USD
Availability: InStock
Rating: 4.9 (3102 reviews)

What is Trulicity® (Dulaglutide)?

Trulicity is a long-acting GLP-1 receptor agonist indicated for adults with type 2 diabetes. It is administered as a once-weekly subcutaneous injection and is used as an adjunct to diet and exercise to improve glycemic control. Many patients also experience clinically meaningful weight reduction and cardiometabolic improvements when Trulicity is used as part of a structured, supervised care plan.

Mechanism of action (GLP-1 receptor agonism)

• Activates GLP-1 receptors to enhance glucose-dependent insulin secretion
• Suppresses inappropriate glucagon secretion in the post-prandial state
• Slows gastric emptying, which can help reduce appetite and food intake
• Supports weight reduction and cardiometabolic risk factor improvement in appropriate patients

Trulicity and other GLP-1 receptor agonists such as Ozempic, Wegovy, Mounjaro and Zepbound work within the same incretin pathway but have different molecules, doses, and labeled indications. Your Vitercure clinician will assess which agent, if any, is appropriate for your profile.

Trulicity for type 2 diabetes control

Trulicity is primarily a type 2 diabetes medication. It improves glycemic control by enhancing glucose-dependent insulin secretion, reducing inappropriate glucagon, and slowing gastric emptying. In clinical practice, this can translate to reductions in fasting glucose, post-prandial excursions, and overall HbA1c.

HbA1c reduction: Many patients achieve clinically meaningful A1c reductions when Trulicity is added to lifestyle interventions and, in some cases, to baseline agents such as metformin.
Hypoglycemia risk: Because its effect is glucose-dependent, Trulicity has a lower intrinsic hypoglycemia risk than insulin; however, risk can increase when combined with sulfonylureas or insulin.
Cardiometabolic profile: GLP-1 receptor agonists are often considered in patients with cardiometabolic risk, though the final decision depends on your full risk profile and current guidelines.

This information is educational and not a substitute for guideline-based care. Your Vitercure clinician will individualize your regimen and may consider alternatives such as phentermine for short-term appetite suppression or other GLP-1 agents when appropriate.

Weight, appetite & metabolic effects

Although Trulicity is not primarily labeled as a weight-loss medication, many patients experience reduced appetite, earlier satiety, and clinically relevant weight loss as part of a comprehensive program designed through Vitercure.

🍽️

Appetite & cravings

GLP-1 activation can blunt appetite signals and help patients adhere more consistently to calorie and portion goals recommended in the Vitercure weight-loss library.

⚖️

Weight trajectory

Many patients see gradual, clinically meaningful weight reduction over months when Trulicity is paired with evidence-based nutrition, movement, and sleep strategies.

🫀

Metabolic health

Improved glycemic control and weight reduction can contribute to better blood pressure, lipids, and overall cardiometabolic risk—goals that your Vitercure team will help you monitor longitudinally.

How to use Trulicity® safely

Administration

Form: Single-use, pre-filled pen for subcutaneous injection.
Frequency: Once weekly, on the same day each week.
Sites: Abdomen, thigh, or upper arm; rotate injection sites.
With food: Can be given with or without food.

Typical dosing framework (example only)

Phase	Weekly dose	Clinical intent
Initiation	0.75mg once weekly	Assess tolerability and begin GLP-1–based glycemic improvement.
Titration / maintenance	1.5mg once weekly (if tolerated and indicated)	Support sustained A1c reduction and metabolic benefits.

These are not prescribing instructions. Your actual starting dose, titration, and duration will be determined by your Vitercure clinician based on your history, labs, comorbidities, and concurrent medications. Never change your dose on your own.

Important safety information

This is not the full list of warnings or side effects. Always review the official Prescribing Information, Medication Guide, and speak with a licensed prescriber before starting or changing any medication.

⚠️

Who should NOT use Trulicity

Personal or family history of medullary thyroid carcinoma (MTC).
Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
History of serious hypersensitivity to dulaglutide or any component of the formulation.
Pregnant or planning pregnancy, unless specifically advised by your clinician.

❤️

Monitoring during GLP-1 therapy

Your Vitercure team may monitor kidney function, blood pressure, weight trajectory, glucose trends, and potential gastrointestinal intolerance. You should promptly report severe abdominal pain, signs of pancreatitis, gallbladder issues, allergic reactions, or significant changes in vision or mood.

Possible side effects

Not every patient will experience side effects, but it is important to understand what may occur and when to seek urgent medical care.

🙂

Common effects

Nausea, vomiting, diarrhea, decreased appetite, indigestion, and fatigue are frequently reported, particularly during initiation and dose escalation. These often improve over time, but persistent or severe symptoms should be discussed with your clinician.

❗

Serious concerns

Severe abdominal pain (with or without vomiting), symptoms suggestive of pancreatitis, difficulty breathing, swelling of the face or throat, chest pain, or signs of severe allergic reaction require urgent medical evaluation and may necessitate discontinuation.

This overview does not replace individualized medical advice. Your Vitercure clinician will review your specific risk profile before prescribing.

Trulicity FAQ

What is Trulicity used for? ▼

Trulicity (dulaglutide) is a once-weekly GLP-1 receptor agonist used to improve blood sugar control in adults with type 2 diabetes. It may also help with weight reduction in many patients when combined with a structured nutrition and movement plan.

Does Trulicity help with weight loss? ▼

Trulicity is not officially classified as a weight-loss drug, but many patients experience weight reduction as a secondary benefit. This effect is thought to be related to appetite regulation, slower gastric emptying, and improved insulin and glucose dynamics.

How often do you inject Trulicity? ▼

Trulicity is injected once weekly, on the same day each week, with or without food, in the abdomen, thigh, or upper arm. Never change your dose or schedule without guidance from a clinician.

Can I take Trulicity with other diabetes medicines? ▼

Trulicity is often used alongside metformin, SGLT2 inhibitors, or basal insulin, but combinations must be individualized. Your prescriber will review your medications, kidney function, and hypoglycemia risk before recommending a regimen.

For deeper education, explore the Vitercure GLP-1 & weight-loss library or speak directly with your care team inside your Vitercure account.

Source USA — 0.75mg/0.5mL pens (starter & bridging)

Source USA — 1.5mg/0.5mL pens (maintenance)